Azurin50 77 cell penetrating peptide p28

Drug Overview

azurin50 77 cell penetrating peptide p28 is a new type of “Smart Drug” designed to fight cancer from the inside. It is a small piece of a protein originally found in a common bacterium. Unlike traditional chemotherapy, p28 is highly selective, meaning it tries to find cancer cells while leaving healthy cells alone.

• Generic Name: Azurin-derived peptide p28 (also known as NSC745104).
• US Brand Names: None (This drug is currently being studied in clinical trials).
• Drug Class: Cell-Penetrating Peptide (CPP); p53 Protein Stabilizer.
• Route of Administration: Intravenous (IV) infusion.
• FDA Approval Status: Investigational. It has received Orphan Drug and Rare Pediatric Disease designations for certain brain tumors, but it is not yet fully approved for general use.
  
  Find expert information on azurin50 77 cell penetrating peptide p28. Trust our premier medical hospital for innovative targeted therapies today.

What Is It and How Does It Work? (Mechanism of Action)

The p28 peptide is a “Targeted Therapy” that acts like a key to unlock the body’s natural cancer-fighting systems. Its job is to fix a broken “off switch” in cancer cells.

Step 1: Entering the Cancer Cell

The peptide is “cell-penetrating,” which means it can walk right through the walls of a cell. It prefers cancer cells over healthy ones. It enters these cells using special entry points on the cell surface called caveolae. Because cancer cells have more of these entry points, p28 gathers inside the tumor much more than in healthy tissue.

Step 2: Protecting the “Guardian of the Genome” (p53)

Inside almost every cell is a protein called p53. This protein is the “guardian” that tells a cell to stop growing or to die if it becomes cancerous. In most cancers, p53 is destroyed by another protein called COP1 (an E3 ubiquitin ligase). COP1 “tags” p53 to be shredded by the cell’s trash compactor (the proteasome).

Step 3: Molecular Blocking

At the molecular level, p28 binds to a specific part of p53 called the DNA-binding domain (DBD). By sitting on this spot, p28 physically blocks COP1 from tagging p53.

• Stabilization: Because COP1 can’t reach it, p53 levels start to rise.
• Cell Cycle Arrest: The high levels of p53 tell the cancer cell to stop dividing at a stage called G2/M.
• Apoptosis: If the cell cannot be fixed, the p53 triggers apoptosis—a programmed “cell suicide” that makes the tumor shrink.

FDA-Approved Clinical Indications

Currently, p28 is used in clinical research. While it is not yet “FDA Approved” for the general market, it is being tested for:

• Oncological Uses:
  • Recurrent or progressive Central Nervous System (CNS) tumors (Brain tumors) in children and adults.
  • Advanced solid tumors that have not responded to other treatments.
  • Metastatic Melanoma.
• Non-oncological Uses:
  • None at this time.

Dosage and Administration Protocols

The dose of p28 is based on the patient’s weight. It is given as a quick liquid drip into a vein.

Adjustments: In clinical trials, this drug has been so well-tolerated that “Maximum Tolerated Doses” were never reached. However, doctors still check liver and kidney function (creatinine clearance >50ml/min) before starting.

Clinical Efficacy and Research Results

Research from 2020 to 2025 has shown that p28 is very safe and can help patients who have run out of other options.

• Tumor Shrinkage: In adult Phase I trials, some patients with metastatic melanoma and colon cancer saw their tumors stop growing (Stable Disease) or shrink (Partial Response) for over a year.
• Pediatric Results: Studies in children with tough-to-treat brain tumors showed the drug was very safe. About 15–20% of children in early studies saw their disease stay stable for several months.
• Brain Penetration: Recent data (2023-2025) confirms that p28 can cross the Blood-Brain Barrier (BBB). This is a big deal because many cancer drugs cannot get into the brain to fight tumors.
• Combination Therapy: New research shows p28 makes radiation and other “Smart Drugs” work better by “sensitizing” the cancer cells.

Safety Profile and Side Effects

One of the best things about p28 is its safety. Because it is so targeted, it has very few side effects compared to chemotherapy.

Black Box Warning: There are currently no Black Box Warnings for p28.

Common Side Effects (>10%)

• Infusion Reaction: Some patients may get a temporary red face or feel warm during the IV drip.
• Mild Fatigue: Feeling a bit tired after the treatment.

Serious Adverse Events

• None consistently reported: In clinical trials so far, no “Dose-Limiting Toxicities” (serious bad reactions) have been found, even at high doses.
• Immune Response: Because it is a bacterial peptide, scientists watch for allergic reactions, but these have been very rare.

Management Strategies

• Slow Infusion: If a patient feels warm or red during the drip, the nurse simply slows down the infusion.
• Monitoring: Doctors check blood counts (CBC) and liver tests (ALT/AST) weekly during the first cycle.

Research Areas

Since p28 is so good at getting into cancer cells and crossing the blood-brain barrier, it is a major focus in Immunotherapy research. Scientists are looking at using p28 as a “delivery truck” to carry other medicines or radioactive markers directly into brain tumors. There is also interest in using p28 to help “wake up” the immune system in tumors that have become “cold” or hidden from the body’s defenses.

Patient Management and Practical Recommendations

Pre-treatment Tests

• p53 Status: A biopsy is often checked to see if the tumor has p53 protein (the target for the drug).
• Organ Health: Blood tests to check that the kidneys and liver are working well.
• Imaging: An MRI or CT scan to measure the tumor before starting.

Precautions During Treatment

• Stay Hydrated: Drink plenty of water on infusion days.
• Report Changes: Tell your doctor if you feel any new headaches or sudden tiredness.

“Do’s and Don’ts”

• DO keep all your scheduled appointments. Since p28 is given 3 times a week, staying on schedule is very important.
• DO tell your doctor about all other medicines you take.
• DON’T ignore a fever. Even though the drug is safe, a fever can be a sign of infection.
• DON’T expect results overnight. It can take several weeks for p53 levels to build up and start shrinking the tumor.

Legal Disclaimer

This guide is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Azurin-derived peptide p28 is an investigational drug and is only available through clinical trials. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options.